+499.5%
MRNA vs REPL
+161.1%
+338.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | REPL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -2.2% |
| 7D | +5.5% | -3.0% | +8.4% | +5.5% |
| 30D | +158.7% | +27.1% | +131.6% | +157.1% |
| 3M | +182.1% | +52.4% | +129.7% | +179.3% |
| 6M | +151.8% | +107.4% | +44.4% | +136.3% |
| YTD | +393.6% | +54.7% | +338.8% | +368.6% |
| 1Y | +499.5% | +158.9% | +340.6% | +445.7% |
| All | +499.5% | +161.1% | +338.4% | +445.7% |
Cumulative growth
Daily Returns
Daily percentage return beside REPL.
Daily Out/Under-Performance
Portfolio return minus REPL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × REPL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded REPL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling